OTLK - Outlook Therapeutics, Inc.
IEX Last Trade
2
0.025 1.250%
Share volume: 10,147
Last Updated: Fri 27 Dec 2024 08:30:19 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.98
0.03
1.27%
Summary score
31%
Profitability
50%
Dept financing
25%
Liquidity
18%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
83.93%
Return on assets
-38.14%
Return on sales
-788.41%
Return on invested capital
77.04%
Total debt ratio
197.13%
Debt ratio change over timeo
2.67%
Current Ratio
0.36%
Quick Ratio
0.56%
Cash Position Ratio
0.25%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
56.39%
Return on assets
-43.47%
Return on sales
-24.29%
Return on invested capital
70.26%
Total debt ratio
206.55%
Debt ratio change over timeo
4.01%
Current Ratio
0.73%
Quick Ratio
0.73%
Cash Position Ratio
0.49%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-27.49%
Return on assets
-38.93%
Return on sales
0%
Return on invested capital
18.33%
Total debt ratio
63.74%
Debt ratio change over time
-0.28%
Current Ratio
1.53%
Quick Ratio
1.53%
Cash Position Ratio
1.3%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
38.95%
Return on assets
-159.46%
Return on sales
-1327.8%
Return on invested capital
27.72%
Total debt ratio
267.48%
Debt ratio change over time
2.67%
Current Ratio
-0.42%
Quick Ratio
-0.08%
Cash Position Ratio
-0.62%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | OTLK | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 83.93% | -3.65% | 12.3% | 6.42% |
| Return on assets | -38.14% | 3.5% | 3.6% | 5.35% |
| Return on sales | -788.41% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 77.04% | 4.99% | 7.81% | 13.62% |
| Profitability | 50% | 37% | 48% | 52% |
| Total debt ratio | 197.13% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | 2.67% | 224.03% | 6.03% | 1.46% |
| Dept financing | 25% | 38% | 10% | 4% |
| Current Ratio | 0.73% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0.73% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 0.49% | 1.41% | 0.73% | 1.41% |
| Liquididy | 12% | 34% | 61% | 74% |
| Short-term ratios | OTLK | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 56.39% | -16.17% | 18.05% | 7.63% |
| Return on assets | -43.47% | 2.71% | 3.58% | 5.03% |
| Return on sales | -24.29% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 70.26% | 6.54% | 5.97% | 19.39% |
| Profitability | 50% | 36% | 53% | 60% |
| Total debt ratio | 206.55% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | 4.01% | 851.68% | 10.97% | 0.58% |
| Dept financing | 25% | 37% | 10% | 4% |
| Current Ratio | 0.73% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0.73% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 0.49% | 1.41% | 0.73% | 1.41% |
| Liquididy | 20% | 56% | 40% | 75% |